AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32253046 — intervention group
Group type: COMPARATOR
Intervention: No educational intervention (initial willingness)
Number of subjects: 156
Study 34151831 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 64
Study 34151831 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation stretching
Number of subjects: 64
Study 33928896 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MCI) consisting of child nutrition education plus family engagement through parental nutrition education, meal preparation and tasting
Number of subjects: 306
Study 33928896 — intervention group
Group type: EXPERIMENTAL
Intervention: Single component intervention (SCI) of child nutrition education
Number of subjects: 306
Study 33928896 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 306
Study 34230023 — intervention group
Group type: EXPERIMENTAL
Intervention: Structure-function (S-F) analysis combining spectral-domain optical coherence tomography (SD-OCT) and standard automated perimetry (SAP)
Number of subjects: 3001
Study 34230023 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard automated perimetry (SAP)
Number of subjects: 3001
Study 34230023 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral-domain optical coherence tomography (SD-OCT)
Number of subjects: 3001
Study 34230023 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification tree approach combining OCT, SAP and defect localisation data
Number of subjects: 3001
Study 34230023 — intervention group
Group type: EXPERIMENTAL
Intervention: Structure-function (S-F) analysis
Number of subjects: 3001
Study 32524231 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose milk protein supplementation (10 g of milk protein daily)
Number of subjects: 122
Study 32524231 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric placebo drink
Number of subjects: 122
Study 32830553 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion during euglycemia
Number of subjects: 0
Study 32830553 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion during hyperglycemia
Number of subjects: 0
Study 32830553 — intervention group
Group type: COMPARATOR
Intervention: Both protocols
Number of subjects: 0
Study 35098970 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasatinib plus quercetin
Number of subjects: 5
Study 32981154 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal jugular vein compression (JVC) using an externally worn neck collar
Number of subjects: 284
Study 32981154 — intervention group
Group type: COMPARATOR
Intervention: Non-collar group (control)
Number of subjects: 284
Study 32474696 — intervention group
Group type: EXPERIMENTAL
Intervention: Local intra-gestational sac methotrexate injection followed by dilation and curettage (D&C)
Number of subjects: 31
Study 35793982 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TA) 750 mg daily for a month after EVAR
Number of subjects: 0
Study 35793982 — intervention group
Group type: COMPARATOR
Intervention: Non-Tranexamic Acid (non-TA)
Number of subjects: 0
Study 34167677 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted thrombolysis (USAT)
Number of subjects: 81
Study 34167677 — intervention group
Group type: COMPARATOR
Intervention: Standard catheter-directed thrombolysis (SCDT)
Number of subjects: 81
Study 32651132 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming (interactive cycling during 6 months)
Number of subjects: 112
Study 32651132 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (control group)
Number of subjects: 112
Study 36208563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-suturing intervention
Number of subjects: 16
Study 36208563 — intervention group
Group type: COMPARATOR
Intervention: Conventional suturing (control)
Number of subjects: 16
Study 33430774 — intervention group
Group type: EXPERIMENTAL
Intervention: Early administration of a small amount of water immediately after recovery from general anesthesia.
Number of subjects: 300
Study 33430774 — intervention group
Group type: COMPARATOR
Intervention: Control group received a small amount of water at 4 to 6 hours after the operation.
Number of subjects: 300
Study 32961681 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippotherapy (30min sessions for 12 weeks, twice a week)
Number of subjects: 45
Study 32961681 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippotherapy (30min sessions for 12 weeks, once a week)
Number of subjects: 45
Study 32961681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hippotherapy)
Number of subjects: 45
Study 35086102 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic intranasal oxytocin (OT) administered daily for 5 days or every other day
Number of subjects: 147
Study 35086102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 34553346 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5mg once daily for 4 to 6 weeks
Number of subjects: 1000
Study 34553346 — intervention group
Group type: COMPARATOR
Intervention: Rivaroxaban 10mg once daily
Number of subjects: 1000
Study 34553346 — intervention group
Group type: COMPARATOR
Intervention: Low molecular weight heparin (intermediate dose)
Number of subjects: 1000
Study 34553346 — intervention group
Group type: COMPARATOR
Intervention: Both study arms (Fondaparinux and Rivaroxaban)
Number of subjects: 1000
Study 33313718 — intervention group
Group type: EXPERIMENTAL
Intervention: Pushing Splints 3 (PS3) therapy
Number of subjects: 48
Study 33313718 — intervention group
Group type: COMPARATOR
Intervention: Rapid maxillary expansion and facemask therapy (RME/FM)
Number of subjects: 48
Study 33112550 — intervention group
Group type: COMPARATOR
Intervention: 4% formalin application
Number of subjects: 34
Study 33112550 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic water irrigation and oral antibiotics (metronidazole and ciprofloxacin)
Number of subjects: 34
Study 33112550 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic water irrigation
Number of subjects: 34
Study 35295073 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin-Pioglitazone (ALO-PIO)
Number of subjects: 99
Study 35295073 — intervention group
Group type: COMPARATOR
Intervention: Alogliptin (ALO)
Number of subjects: 99
Study 35295073 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride (GLIM)
Number of subjects: 99
Study 32846108 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced carbohydrate counting (ACC) and use of an automated bolus calculator (ABC)
Number of subjects: 79
Study 32846108 — intervention group
Group type: COMPARATOR
Intervention: Manual calculation of insulin bolus (MC)
Number of subjects: 79
Study 34255075 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (30 minutes of moderate aerobic exercise)
Number of subjects: 92
Study 34255075 — intervention group
Group type: COMPARATOR
Intervention: Control (sitting and reading for 30 minutes)
Number of subjects: 92
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: Kane keratoconus formula
Number of subjects: 147
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: SRK/T
Number of subjects: 147
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrett Universal 2
Number of subjects: 147
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmodified Kane
Number of subjects: 147
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: Holladay 1
Number of subjects: 147
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmodified Holladay 2
Number of subjects: 147
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: Haigis
Number of subjects: 147
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: Hoffer Q
Number of subjects: 147
Study 32279887 — intervention group
Group type: EXPERIMENTAL
Intervention: Holladay 2 with keratoconus adjustment
Number of subjects: 147
Study 32279887 — intervention group
Group type: COMPARATOR
Intervention: Normal IOL formulas (Barrett Universal 2, Haigis, Hoffer Q, Holladay 1, Holladay 2, Kane, SRK/T)
Number of subjects: 147
Study 35667959 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH VN intervention (in‐home, multicomponent, family caregiver support intervention delivered over two to three months)
Number of subjects: 60
Study 35667959 — intervention group
Group type: COMPARATOR
Intervention: Enhanced control group
Number of subjects: 60
Study 34889153 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish classical music therapy (6 sessions, 10 minutes each)
Number of subjects: 60
Study 34397423 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0
Study 34397423 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32070246 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) supplementation (8 μg/kg birthweight/day as a single daily dose)
Number of subjects: 153
Study 32070246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 35411074 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin therapy (10 mg and 25 mg, orally administered, 7 days apart)
Number of subjects: 0
Study 35411074 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin therapy (2 × 25 mg, orally administered, 3 weeks apart, plus 6 weeks of daily placebo)
Number of subjects: 0
Study 35411074 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (2 × 1 mg, orally administered, 3 weeks apart, plus 6 weeks of daily escitalopram 10–20 mg)
Number of subjects: 0
Study 34195900 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation, sentinel lymph node biopsy, or elective neck dissection for management of the cN0 neck
Number of subjects: 0
Study 34195900 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus adjuvant radiation
Number of subjects: 0
Study 34195900 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 0
Study 32078337 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 sessions/week REHIT
Number of subjects: 42
Study 32078337 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sessions/week REHIT
Number of subjects: 42
Study 32078337 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 sessions/week REHIT
Number of subjects: 42
Study 33632018 — intervention group
Group type: EXPERIMENTAL
Intervention: Operational definitions of constructs (performance, achievement, success)
Number of subjects: 262
Study 33632018 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of job performance via self-rating indicators
Number of subjects: 262
Study 33632018 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of GPA as a universal indicator of academic outcomes
Number of subjects: 262
Study 34933978 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamas for Change (community-based women's health education program)
Number of subjects: 1273
Study 34933978 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (monthly home visits)
Number of subjects: 1273
Study 34618479 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted cognitive behavioral therapy (CA‐CBT)
Number of subjects: 23
Study 34618479 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 23
Study 34226737 — intervention group
Group type: EXPERIMENTAL
Intervention: FMT-LF
Number of subjects: 70
Study 34226737 — intervention group
Group type: EXPERIMENTAL
Intervention: FMT-HF
Number of subjects: 70
Study 34226737 — intervention group
Group type: EXPERIMENTAL
Intervention: HF
Number of subjects: 70
Study 34226737 — intervention group
Group type: EXPERIMENTAL
Intervention: LF
Number of subjects: 70
Study 32334074 — intervention group
Group type: EXPERIMENTAL
Intervention: Active NBM DBS stimulation
Number of subjects: 6
Study 32334074 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 6
Study 35457291 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 41
Study 35457291 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring (Control)
Number of subjects: 41
Study 32598502 — intervention group
Group type: EXPERIMENTAL
Intervention: Dim light melatonin onset (DLMO) measurement
Number of subjects: 73
Study 32598502 — intervention group
Group type: EXPERIMENTAL
Intervention: Actigraphy measurement of sleep onset time
Number of subjects: 73
Study 32598502 — intervention group
Group type: EXPERIMENTAL
Intervention: Morningness-eveningness questionnaire (MEQ)
Number of subjects: 73
Study 32598502 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 73
Study 32598502 — intervention group
Group type: EXPERIMENTAL
Intervention: Light exposure and activity rhythms
Number of subjects: 73
Study 34266855 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 139002
Study 34266855 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes in women
Number of subjects: 139002
Study 34266855 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes in men
Number of subjects: 139002
Study 34266855 — intervention group
Group type: COMPARATOR
Intervention: Control group (adults without type 2 diabetes)
Number of subjects: 139002
Study 32316984 — intervention group
Group type: EXPERIMENTAL
Intervention: LOCal Assessment and Triage Evaluation (LOCATE) model of care
Number of subjects: 234
Study 32316984 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 234
Study 33992297 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct myofascial release (MFR) on the posterior thigh region
Number of subjects: 68
Study 33992297 — intervention group
Group type: COMPARATOR
Intervention: Placebo technique
Number of subjects: 68
Study 32528340 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) psychotherapy plus prenatal usual care (PUC)
Number of subjects: 70
Study 32528340 — intervention group
Group type: COMPARATOR
Intervention: Prenatal usual care (PUC)
Number of subjects: 70
Study 33563873 — intervention group
Group type: EXPERIMENTAL
Intervention: DWISTIR (short‐inversion time inversion‐recovery)
Number of subjects: 77
Study 33563873 — intervention group
Group type: COMPARATOR
Intervention: DWISTIR+SSRF (spectral‐spatial RF)
Number of subjects: 77
Study 33563873 — intervention group
Group type: EXPERIMENTAL
Intervention: DWISTIR and DWISTIR+SSRF
Number of subjects: 77
Study 34849429 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (1000 mg in 150 ml normal saline)
Number of subjects: 185
Study 34849429 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg in 150 ml normal saline)
Number of subjects: 185
Study 32524424 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated efavirenz concentration (≥ 4.0 mg/L)
Number of subjects: 54
Study 32524424 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to rilpivirine (after discontinuing efavirenz)
Number of subjects: 54
Study 32524424 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma neurofilament light (Nfl) levels
Number of subjects: 54
Study 35463209 — intervention group
Group type: EXPERIMENTAL
Intervention: New radial artery hemostasis device (CD group)
Number of subjects: 60
Study 35463209 — intervention group
Group type: COMPARATOR
Intervention: TR Band (TR group)
Number of subjects: 60
Study 33299890 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg per day)
Number of subjects: 36
Study 36001526 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week intensive trabeculectomy surgical simulation course
Number of subjects: 49
Study 36001526 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study 33720272 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard OMT
Number of subjects: 200
Study 33720272 — intervention group
Group type: COMPARATOR
Intervention: Sham OMT
Number of subjects: 200
Study 32492913 — intervention group
Group type: EXPERIMENTAL
Intervention: Monomeric and oligomeric flavanols (MOF)
Number of subjects: 0
Study 32492913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36104664 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-titrating positive airway pressure (APAP) for 72 hours postoperatively or until discharge
Number of subjects: 234
Study 36104664 — intervention group
Group type: COMPARATOR
Intervention: Routine care after surgery
Number of subjects: 234
Study 36104664 — intervention group
Group type: EXPERIMENTAL
Intervention: APAP
Number of subjects: 234
Study 36104664 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 234
Study 36104664 — intervention group
Group type: COMPARATOR
Intervention: APAP vs. Routine care
Number of subjects: 234
Study 34127046 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake prone positioning (16 hours per day)
Number of subjects: 75
Study 34127046 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 75
Study 34173063 — intervention group
Group type: EXPERIMENTAL
Intervention: OMIS + NRCT + NDT‐B (n = 20)
Number of subjects: 40
Study 34173063 — intervention group
Group type: COMPARATOR
Intervention: OMIS + NRCT (n = 20)
Number of subjects: 40
Study 36363460 — intervention group
Group type: EXPERIMENTAL
Intervention: Ormeloxifene
Number of subjects: 367
Study 36363460 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate
Number of subjects: 367
Study 32250057 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam (single intravenous injection)
Number of subjects: 62
Study 33032771 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous golimumab 2 mg/kg
Number of subjects: 480
Study 33032771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study 35394678 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 161
Study 35394678 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper intrauterine device (IUD)
Number of subjects: 161
Study 35394678 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA-IM)
Number of subjects: 161
Study 35394678 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups with low baseline inflammation
Number of subjects: 161
Study 35394678 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups with high baseline inflammation
Number of subjects: 161
Study 32978200 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg or 150 mg two times per day
Number of subjects: 686
Study 32978200 — intervention group
Group type: COMPARATOR
Intervention: Warfarin with international normalised ratio 2-3
Number of subjects: 686
Study 35552386 — intervention group
Group type: EXPERIMENTAL
Intervention: LED-mediated photobiomodulation (PBM) with 850 nm wavelength, 60 mW/cm2 power, continuous LED illumination for 5 minutes/day
Number of subjects: 20
Study 35552386 — intervention group
Group type: COMPARATOR
Intervention: Control (no LED treatment)
Number of subjects: 20
Study 33408282 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hourly feeding schedule
Number of subjects: 350
Study 33408282 — intervention group
Group type: COMPARATOR
Intervention: 3-hourly feeding schedule
Number of subjects: 350
Study 32041644 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose EAA/protein composition (12.6g protein, 3.2g EAA per serving)
Number of subjects: 0
Study 32041644 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose EAA/protein composition (6.3g protein, 1.6g EAA per serving)
Number of subjects: 0
Study 32041644 — intervention group
Group type: COMPARATOR
Intervention: Gatorade Recover (17g; 12.6g protein)
Number of subjects: 0
Study 36123932 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic balance exercise (DBE)
Number of subjects: 36
Study 33247575 — intervention group
Group type: EXPERIMENTAL
Intervention: Binaural beats (220 Hz for right ear, 210 Hz for left ear) for 10 minutes
Number of subjects: 90
Study 33247575 — intervention group
Group type: EXPERIMENTAL
Intervention: 432 Hz tuned music for 10 minutes
Number of subjects: 90
Study 33247575 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 90
Study 32202262 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower trapezius strengthening exercise program, applied 3 times per week for 4 weeks.
Number of subjects: 40
Study 32202262 — intervention group
Group type: COMPARATOR
Intervention: Scapula and thoracic spine stabilization exercise program (same for both groups).
Number of subjects: 40
Study 32202262 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower trapezius strengthening exercise program.
Number of subjects: 40
Study 35506577 — intervention group
Group type: EXPERIMENTAL
Intervention: Incenter Brochure plus Email
Number of subjects: 0
Study 35506577 — intervention group
Group type: COMPARATOR
Intervention: Email Only
Number of subjects: 0
Study 35506577 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 34436509 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib (400 mg/d) + standard of care (SOC: 40 mg dihydroartemisinin + 320 mg piperaquine/d)
Number of subjects: 0
Study 34436509 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC: 40 mg dihydroartemisinin + 320 mg piperaquine/d)
Number of subjects: 0
Study 34875022 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous iron
Number of subjects: 0
Study 34875022 — intervention group
Group type: COMPARATOR
Intervention: Low-dose intravenous iron
Number of subjects: 0
Study 33638612 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 0
Study 33638612 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 0
Study 33638612 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor allele carriers (A/A) of rs9827586
Number of subjects: 0
Study 33638612 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor allele carriers (A/A) of rs701109
Number of subjects: 0
Study 33829920 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily sustained physical activity (PA)
Number of subjects: 277
Study 32235773 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk Protein Isolate (MPI) - 0.7 g protein/kg/d
Number of subjects: 44
Study 32235773 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) - 0.7 g carbohydrate/kg/d
Number of subjects: 44
Study 33945886 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirmation followed by gain-framed health messages daily
Number of subjects: 80
Study 33945886 — intervention group
Group type: COMPARATOR
Intervention: Daily loss-framed health messages only
Number of subjects: 80